Peter is a registered patent agent with research and industry experience in biomedical engineering. He focuses his practice on US and international patent prosecution and strategic patent counseling, primarily for clients in the life sciences, medical devices, biotechnology, and pharmaceuticals industries.

Peter has extensive patenting experience in the areas of stem cell technology, genetic engineering, cell therapy, diabetic wound healing, cardiovascular disease, neurodegeneration, neuroinflammation, GLP drug development, biomechanics, and microfluidics. His practice also encompasses counseling clients on patent portfolio strategy, advising on freedom-to-operate issues, and performing intellectual property diligence analysis. Peter also has experience handling post-grant proceedings, including appeals at the Patent Trial and Appeal Board and the US Court of Appeals for the Federal Circuit.

Prior to joining Mintz, Peter worked as a patent agent at an international law firm. Earlier, he held several postdoctoral positions that drew on his PhD research exploring the use of adult stem cells to treat vascular dysfunction. In those roles, Peter developed methods for genetically engineering and differentiating human pluripotent stem cells to model cardiovascular and neurological diseases. He had fellowships with the Department of Neurology at the University of Washington and the Seattle Institute for Biomedical and Clinical Research, where he conducted research at the Veteran Affairs Puget Sound Health Care System. He was also a postdoctoral associate at the Cardiovascular Research Center of Yale University’s School of Medicine.

Prior to his PhD studies, Peter worked as a bioanalytical analyst at a research organization based in New Jersey.